Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Histiocytoma, Malignant Fibrous × Dactinomycin × Clear all

Sponsor

Conditions

Rhabdomyosarcoma 5 Sarcoma 4 Wilms Tumor 2 Hydatidiform Mole 2 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Melanoma 1 Malignant mesenchymal tumor 1 Lymphoma 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia 1 Fibrosarcoma 1 Choroid Plexus Neoplasms 1 Choriocarcinoma 1 Carcinoma, Renal Cell 1 Brain Neoplasms 1 Blast Crisis 1 Beckwith-Wiedemann Syndrome 1

Interventions

Doxorubicin 5 pazopanib 3 Ifosfamide 3 pembrolizumab 2 Sunitinib 2 Radiotherapy, Conformal 2 Radiotherapy 2 tremelimumab 1 temsirolimus 1 sintilimab 1 saracatinib 1 romidepsin 1 olaratumab 1 liposomal doxorubicin 1 indolepropanol phosphate 1 eribulin 1 durvalumab 1 Watchful Waiting 1 Surgical Procedures, Operative 1 Sorafenib 1 Razoxane 1 Radiotherapy, Intensity-Modulated 1 Radiation 1 Polymerase Chain Reaction 1 Observation 1 Nivolumab 1 Neoadjuvant Therapy 1 Methotrexate 1 MLN 8237 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡